These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1165145

  • 1. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM, Kumana CR, Franklin DA, Baker LR.
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [Abstract] [Full Text] [Related]

  • 2. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP, Houin G, Ledudal P, Cautreels W, Giudicelli CP, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Jul; 4(3):165-73. PubMed ID: 6149194
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of oral cefatrizine in patients with impaired renal function.
    Couet W, Fauvel JP, Laville M, Pozet N, Fourtillan JB.
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E, d'Athis P, Richard MO, Fillastre JP, Olive G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [Abstract] [Full Text] [Related]

  • 5. Plasma and urinary catecholamines and their metabolites in chronic renal failure.
    Darwish R, Elias AN, Vaziri ND, Pahl M, Powers D, Stokes JD.
    Arch Intern Med; 1984 Jan; 144(1):69-71. PubMed ID: 6691776
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S, Guay D, Opsahl J, Tack K, Matzke G.
    Int J Clin Pharmacol Res; 1991 Jan; 11(3):115-21. PubMed ID: 1809697
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G, Cavaliere G, D'Amico G, Passarella E, Broccali G.
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [Abstract] [Full Text] [Related]

  • 8. The kinetics of aminosidine in renal patients with different degrees of renal failure.
    Novarini A, Montanari A, Bruschi G, Rossi E, Borghetti A, Migone L.
    Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346
    [Abstract] [Full Text] [Related]

  • 9. Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin.
    Lefèvre G, Duval M, Gauron S, Brookman LJ, Rolan PE, Morris TM, Piraino AJ, Morgan JM, Palmisano M, Close P.
    Clin Pharmacol Ther; 1997 Jul; 62(1):50-9. PubMed ID: 9246019
    [Abstract] [Full Text] [Related]

  • 10. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
    Wu MJ, Ing TS, Soung LS, Daugirdas JT, Hano JE, Gandhi VC.
    Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A, Drouguett MT, Fuentes G, González G, González C, Thambo S, Palombo G.
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [Abstract] [Full Text] [Related]

  • 12. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
    Gillotin C, Bagnis C, Mamet JP, Peck RW, Deray G.
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835
    [Abstract] [Full Text] [Related]

  • 13. Cimetidine kinetics in renal transplant recipients.
    Keller E, Bozkurt F, Schollmeyer P, Hoppe-Seyler G.
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):274-7. PubMed ID: 3525426
    [Abstract] [Full Text] [Related]

  • 14. Nitrazepam clearance unimpaired in patients with renal insufficiency.
    Ochs HR, Oberem U, Greenblatt DJ.
    J Clin Psychopharmacol; 1992 Jun; 12(3):183-5. PubMed ID: 1629384
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
    Viotte G, Leroy A, Godin M, Fillastre JP.
    Nouv Presse Med; 1982 Nov 18; 11(46):3414-8. PubMed ID: 7155849
    [Abstract] [Full Text] [Related]

  • 16. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec 18; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 17. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO, Tucker GT.
    Afr J Med Med Sci; 1982 Mar 18; 11(1):7-9. PubMed ID: 6291357
    [Abstract] [Full Text] [Related]

  • 18. [Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?].
    Rameis H, Hitzenberger G, Jaschek I, Graninger W.
    Dtsch Med Wochenschr; 1980 Nov 21; 105(47):1650-4. PubMed ID: 7439047
    [Abstract] [Full Text] [Related]

  • 19. Influence of the hemodialysis on the half-life of practolol in patients with severe renal failure.
    Harvengt C, Desager JP, Muschart JM, Tjandramaga YB, Verbeeck R, Verberckmoes R.
    J Clin Pharmacol; 1975 Nov 21; 15(8-9):605-10. PubMed ID: 1167308
    [Abstract] [Full Text] [Related]

  • 20. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE, Spring P, Dettli L.
    Dtsch Med Wochenschr; 1974 Sep 13; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.